AUROPHARMA.BOAUROPHARMA.BO
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average, slight contraction.
Left:
||||
Year-over-year research & development expense growth
Latest
11.14%
↓ 39% below average
Average (9y)
18.36%
Historical baseline
Range
High:58.51%
Low:-10.57%
CAGR
-5.4%
Structural decline
| Period | Value |
|---|---|
| 2025 | 11.14% |
| 2024 | 4.79% |
| 2023 | -10.57% |
| 2022 | 6.60% |
| 2021 | 58.51% |
| 2020 | 10.71% |
| 2019 | 29.71% |
| 2018 | 22.80% |
| 2017 | 31.64% |
| 2016 | 18.33% |